The study highlights the importance of including patient self-assessment—and not just clinician assessment—when planning ...

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...

For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events ...

The addition of subcutaneous daratumumab to triplet therapy improved outcomes for certain patients with newly diagnosed ...

While there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and ...

"support the potential for Blenrep combinations to become standard of care" in multiple myeloma patients at or after their first relapse. The company previously teased the overall survival (OS ...

The Da Nang Hospital announced on March 31 that its department of neurology – musculoskeletal – clinical hematology has ...

Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.

A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled “NSD2-epigenomic reprogramming and ...

Adam Perry shares the story of his journey discussing his diagnosis, treatment and the importance of early detection.

This is Allison’s personal multiple myeloma story, and others may be different. Allison is a paid spokesperson for GSK.